Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis

Drug Delivery

Volumn 22, Issue 3, 2015, Pages 328-334

  Kaur, Mandeep ^a   Malik, Basant ^a   Garg, Tarun ^a   Rath, Goutam ^a   Goyal, Amit K ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Ag85A; Guar gum; Nanoparticles; Oral vaccine; Tuberculosis

Indexed keywords

AG85A ANTIGEN; BCG VACCINE; GUAR GUM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MYCOBACTERIUM ANTIGEN; NANOCARRIER; UNCLASSIFIED DRUG; ACYLTRANSFERASE; ANTIGEN 85A, MYCOBACTERIUM TUBERCULOSIS; BACTERIAL ANTIGEN; DRUG CARRIER; GALACTAN; MANNAN; NANOPARTICLE; PLANT GUM;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN PRESENTATION; ARTICLE; BCG VACCINATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG SAFETY; FEMALE; HUMORAL IMMUNITY; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PARTICLE SIZE; PEYER PATCH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; SURFACE PROPERTY; TUBERCULOSIS; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG RELEASE; IMMUNOLOGY; MEDICINAL CHEMISTRY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; ORAL DRUG ADMINISTRATION;

ACYLTRANSFERASES; ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, BACTERIAL; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG LIBERATION; GALACTANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MANNANS; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; MYCOBACTERIUM TUBERCULOSIS; NANOPARTICLES; PARTICLE SIZE; PEYER'S PATCHES; PLANT GUMS; SURFACE PROPERTIES; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 84930446861     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.894594     Document Type: Article

References (28)

1. Adikwu MU. (2009). Biopolymers in drug delivery: recent advances and challenges. Bentham Science Publishers, 1-198. (DOI: 10.2174/ 97816080507891090101).
2. Apostolopoulos V, Barnes N, Pietersz GA, McKenzie IF (2000). Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses. Vaccine 18:3174-84.
3. Colditz GA, Brewer TF, Berkey CS, et al. (1994). Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-Analysis of the published literature. JAMA 271:698-702.
4. Collnot E-M, Ali H, Lehr C-M. (2012). Nano-And microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J Control Release 161:235-46.
5. Conner SD, Schmid SL. (2003). Regulated portals of entry into the cell. Nature 422:37-44.
6. Cummings J, Branch W, Jenkins D, et al. (1978). Colonic response to dietary fibre from carrot, cabbage, apple, bran, and guar gum. Lancet 311:5-9.
7. Dou J, Chen JS, Wang J, et al. (2005). Novel constructs of tuberculosis gene vaccine and its immune effect on mice. Cell Mol Immunol 2: 57-62.
8. Engering AJ, Cella M, Fluitsma D, et al. (1997a). The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur J Immunol 27:2417-25.
9. Engering AJ, Cella M, Fluitsma DM, et al. (1997b). Mannose receptor mediated antigen uptake and presentation in human dendritic cells. Adv Exp Med Biol 417:183-7.
10. Frey A, Giannasca KT, Weltzin R, et al. (1996). Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med 184:1045-59.
11. Frey A, Neutra MR. (1997). Targeting of mucosal vaccines to Peyers patch M cells. Behring Institute Mitteilungen 98:376-89.
12. Garg T, Singh O, Arora S, Murthy R. (2012). Scaffold: a novel carrier for cell and drug delivery. Crit Rev Therap Drug Carrier Systems 29: 1-63.
13. Garg T, Singh S, Goyal AK. (2013). Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Therap Drug Carrier Systems 30:369-409.
14. Gebert A, Rothkotter HJ, Pabst R. (1996). M cells in Peyers patches of the intestine. Intern Rev Cytol 167:91-159.
15. Guo M, Gong S, Maric S, et al. (2000). A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells. Human Immunol 61:729-38.
16. Launois P, DeLeys R, Niang MN, et al. (1994). T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun 62:3679-87.
17. Lelouard H, Fallet M, de Bovis B, et al. (2012). Peyers patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores. Gastroenterology 142:592-601.
18. Li X, Kong X, Shi S, et al. (2008). Preparation of alginate coated chitosan microparticles for vaccine delivery. BMC Biotechnol 8:89.
19. Lizee G, Basha G, Jefferies WA. (2005). Tails of wonder: endocyticsorting motifs key for exogenous antigen presentation. Trends Immunol 26:141-9.
20. Malik B, Goyal AK, Markandeywar T, et al. (2012). Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization. J Drug Target 20:76-84.
21. Mogues T, Goodrich ME, Ryan L, et al. (2001). The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 193: 271-80.
22. Prabaharan M. (2011). Prospective of guar gum and its derivatives as controlled drug delivery systems. Int J Biol Macromol 49: 117-24.
23. Prasad YV, Krishnaiah YS, Satyanarayana S. (1998). In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J Control Release 51:281-7.
24. Regnault A, Lankar D, Lacabanne V, et al. (1999). Fcgamma receptormediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 189:371-80.
25. Sallusto F, Cella M, Danieli C, Lanzavecchia A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182:389-400.
26. Tascon RE, Stavropoulos E, Lukacs KV, Colston MJ. (1998). Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. Infect Immun 66:830-4.
27. Van Der Lubben I, Konings F, Borchard G, et al. (2001b). In vivo uptake of chitosan microparticles by murine Peyers patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry. J Drug Target 9:39-47.
28. Van der Lubben I, Verhoef J, Van Aelst A, et al. (2001a). Chitosan microparticles for oral vaccination:: preparation, characterization and preliminary in vivo uptake studies in murine Peyers patches. Biomaterials 22:687-94.